Literature DB >> 11076990

Coronary artery bypass graft surgery: socioeconomic inequalities in access and in 30 day mortality. A population-based study in Rome, Italy.

C Ancona1, N Agabiti, F Forastiere, M Arcà, D Fusco, S Ferro, C A Perucci.   

Abstract

OBJECTIVES: To evaluate whether coronary artery bypass graft (CABG) surgery is equally provided among different socioeconomic status (SES) groups in accordance with need. To estimate the association between SES and mortality occurring 30 days after CABG surgery.
DESIGN: Individual socioeconomic index assigned with respect to the characteristics of the census tract of residence (level I = highest SES; level IV = lowest SES). Comparison of age adjusted hospital admission rates of ischaemic heart disease (IHD) and CABG surgery among four SES groups. Retrospective cohort study of all patients who underwent CABG surgery during 1996-97.
SETTING: Rome (2 685 890 inhabitants) and the seven cardiac surgery units in the city. PARTICIPANTS: All residents in Rome aged 35 years or more. A cohort of 1875 CABG patients aged 35 years or more. MAIN OUTCOME MEASURES: Age adjusted hospitalisation rates for CABG and IHD and rate of CABG per 100 IHD hospitalisations by SES group, taking level I as the reference group. Odds ratios of 30 day mortality after CABG surgery, adjusted for age, gender, illness severity at admission, and type of hospital where CABG was performed.
RESULTS: People in the lowest SES level experienced an excess in the age adjusted IHD hospitalisation rates compared with the highest SES level (an excess of 57% among men, and of 94% among women), but the rate of CABG per 100 IHD hospitalisations was lower, among men, in the most socially disadvantaged level (8.9 CABG procedures per 100 IHD hospital admissions in level IV versus 14.1 in level I rate ratio= 0.63; 95% CI 0.44, 0.89). The most socially disadvantaged SES group experienced a higher risk of 30 day mortality after CABG surgery (8. 1%) than those in the highest SES group (4.8%); this excess in mortality was confirmed even when initial illness severity was taken into account (odds ratio= 2.89; 95% CI 1.44, 5.80).
CONCLUSIONS: The universal coverage of the National Health Service in Italy does not guarantee equitable access to CABG surgery for IHD patients. Factors related to SES are likely to influence poor prognosis after CABG surgery.

Entities:  

Mesh:

Year:  2000        PMID: 11076990      PMCID: PMC1731596          DOI: 10.1136/jech.54.12.930

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  36 in total

1.  Inequality in health: socioeconomic differentials in mortality in Rome, 1990-95.

Authors:  P Michelozzi; C A Perucci; F Forastiere; D Fusco; C Ancona; V Dell'Orco
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

2.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.

Authors:  N Krieger
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

3.  Comparison of uninsured and privately insured hospital patients. Condition on admission, resource use, and outcome.

Authors:  J Hadley; E P Steinberg; J Feder
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

4.  Blacks in the coronary artery surgery study (CASS): race and clinical decision making.

Authors:  C Maynard; L D Fisher; E R Passamani; T Pullum
Journal:  Am J Public Health       Date:  1986-12       Impact factor: 9.308

5.  Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction.

Authors:  D A Alter; C D Naylor; P Austin; J V Tu
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

6.  Interracial access to selected cardiac procedures for patients hospitalized with coronary artery disease in New York State.

Authors:  E L Hannan; H Kilburn; J F O'Donnell; G Lukacik; E P Shields
Journal:  Med Care       Date:  1991-05       Impact factor: 2.983

7.  Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients.

Authors:  K C Goldberg; A J Hartz; S J Jacobsen; H Krakauer; A A Rimm
Journal:  JAMA       Date:  1992-03-18       Impact factor: 56.272

8.  Comparison of percutaneous transluminal coronary angioplasty versus coronary artery bypass grafting for multivessel coronary artery disease.

Authors:  J L Vacek; T L Rosamond; H W Stites; S K Rowe; W Robuck; G Dittmeier; G D Beauchamp
Journal:  Am J Cardiol       Date:  1992-03-01       Impact factor: 2.778

9.  Sex bias in considering coronary bypass surgery.

Authors:  J N Tobin; S Wassertheil-Smoller; J P Wexler; R M Steingart; N Budner; L Lense; J Wachspress
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

10.  Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts.

Authors:  M B Wenneker; A M Epstein
Journal:  JAMA       Date:  1989-01-13       Impact factor: 56.272

View more
  28 in total

Review 1.  The meaning and goals of equity in health.

Authors:  W-C Chang
Journal:  J Epidemiol Community Health       Date:  2002-07       Impact factor: 3.710

2.  Geographically Derived Socioeconomic Factors to Improve Risk Prediction in Patients Having Aortic Valve Replacement.

Authors:  Fenton H McCarthy; Lingjiao Zhang; Vicky Tam; Jinbo Chen; Chase Brown; William L Patrick; Walter Clark Hargrove; Wilson Y Szeto; Nimesh D Desai; Douglas J Wiebe; Peter W Groeneveld; Matthew L Williams
Journal:  Am J Cardiol       Date:  2018-09-26       Impact factor: 2.778

3.  Associations of area based deprivation status and individual educational attainment with incidence, treatment, and prognosis of first coronary event in Rome, Italy.

Authors:  Sally Picciotto; Francesco Forastiere; Massimo Stafoggia; Daniela D'Ippoliti; Carla Ancona; Carlo A Perucci
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

4.  Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality.

Authors:  Jarrod E Dalton; David A Zidar; Belinda L Udeh; Manesh R Patel; Jesse D Schold; Neal V Dawson
Journal:  Med Care       Date:  2016-06       Impact factor: 2.983

5.  Socioeconomic status and ischaemic heart disease mortality in 10 western European populations during the 1990s.

Authors:  M Avendano; A E Kunst; M Huisman; F V Lenthe; M Bopp; E Regidor; M Glickman; G Costa; T Spadea; P Deboosere; C Borrell; T Valkonen; R Gisser; J-K Borgan; S Gadeyne; J P Mackenbach
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

6.  Inequalities in coronary revascularisation during the 1990s: evidence from the British regional heart study.

Authors:  R W Morris; P H Whincup; O Papacosta; M Walker; A Thomson
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

7.  Nationwide variation in outcomes and cost of laparoscopic procedures.

Authors:  Ciara R Huntington; Tiffany C Cox; Laurel J Blair; Tanushree Prasad; Amy E Lincourt; B Todd Heniford; Vedra A Augenstein
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

8.  Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.

Authors:  P R Ward; P R Noyce; A S St Leger
Journal:  J Epidemiol Community Health       Date:  2004-02       Impact factor: 3.710

9.  Socioeconomic status, status inconsistency and risk of ischaemic heart disease: a prospective study among members of a statutory health insurance company.

Authors:  Richard Peter; Holger Gässler; Siegfried Geyer
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

10.  Temporal and geographic heterogeneity of the association between socioeconomic position and hospitalisation in Italy: an income based indicator.

Authors:  Patrizia Schifano; Chiara Marinacci; Giulia Cesaroni; Valeria Belleudi; Nicola Caranci; Antonio Russo; Carlo A Perucci
Journal:  Int J Equity Health       Date:  2009-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.